209 studies found for:    Emtricitabina/ Fumarato de disoproxilo de tenofovir OR Truvada[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Safety and Efficacy Study of Switching From Epzicom to Truvada
Condition: HIV Infection
Interventions: Drug: emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF);   Drug: abacavir (ABC)/lamivudine (3TC)
22 Completed A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)
Condition: HIV Infections
Interventions: Drug: Doravirine;   Drug: Efavirenz;   Drug: TRUVADA®
23 Completed Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
24 Withdrawn A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Drug: Raltegravir plus Truvada;   Drug: Atripla
25 Completed Combination of Efavirenz and Truvada - COMET Study
Condition: HIV Infections
Interventions: Drug: Truvada;   Drug: efavirenz
26 Active, not recruiting Evaluating the Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Healthy, HIV-Uninfected Adolescents
Condition: HIV Infections
Intervention: Drug: Truvada
27 Completed
Has Results
Atripla to Raltegravir Switch Study for CNS Toxicity
Condition: HIV Infection
Intervention: Drug: Truvada/Raltegravir
28 Completed
Has Results
Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
Condition: HIV Infections
Interventions: Drug: Etravirine (Intelence);   Drug: Truvada
29 Active, not recruiting Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Condition: HIV Infection
Interventions: Drug: Reformulated Raltegravir;   Drug: Raltegravir;   Drug: TRUVADA™;   Drug: Placebo to Reformulated Raltegravir;   Drug: Placebo to Raltegravir
30 Completed
Has Results
A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)
Condition: HIV Infections
Interventions: Drug: MK-0518;   Drug: Comparator: efavirenz;   Drug: Comparator: Truvada;   Drug: Comparator: Placebo to MK-0518;   Drug: Comparator: Placebo to efavirenz
31 Unknown  A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection
Conditions: Infection;   HIV
Intervention: Drug: Truvada and Isentress
32 Completed
Has Results
HIV Non Occupational Post-Exposure Prophylaxis (PEP)
Condition: HIV Infections
Intervention: Drug: TRUVADA + raltegravir
33 Withdrawn SCOPE: Strategies to Combine PrEP With Prevention Efforts
Condition: HIV
Intervention: Drug: Once daily Truvada®
34 Recruiting Pre-exposure Option for Reducing HIV in the UK.(PROUD)
Condition: HIV
Intervention: Drug: Truvada (once daily tablet containing 300mg tenofovir disoproxil (TDF) and 200mg of emtricitabine (FTC)
35 Completed Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: raltegravir plus truvada;   Drug: Darunavir, ritonavir, tenofovir/emtricitabine (Truvada)
36 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
37 Completed SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: zidovudine and lamivudine (Combivir®);   Drug: emtricitabine and tenofovir DF
38 Terminated The First Failure Study
Conditions: HIV;   HIV Infections
Interventions: Drug: Darunavir, Ritonavir, Truvada;   Drug: Darunavir, Ritonavir and Etravirine
39 Recruiting Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
Condition: HIV
Interventions: Drug: Truvada qd;   Drug: Maraviroc 300 qd
40 Completed Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)
Condition: HIV Infections
Interventions: Drug: Vicriviroc;   Drug: emtricitabine and tenofovir disoproxil fumarate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years